GlassScriptPhysician profile
Muhib Khan
NPI 1043452337
$7,782.77
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,120 · 2020: $32.52 · 2021: $260 · 2022: $5,308 · 2023: $1,033 · 2024: $28.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $5,142.62 | 2019-2022 | |
| Medtronic Vascular, INC. | $1,102.00 | 2019 | |
| Medtronic, INC. | $592.50 | 2022-2023 | Intellis Adaptivestim |
| Microtransponder, INC. | $485.52 | 2023 | |
| Novartis Pharmaceuticals Corporation | $193.77 | 2021-2022 | |
| Genentech, INC. | $131.18 | 2022-2024 | Tnkase |
| Novo Nordisk INC | $63.74 | 2022 | |
| Portola Pharmaceuticals, LLC | $32.52 | 2020 | |
| Ucb, INC. | $19.54 | 2023 | Briviact |
| Neurelis, INC. | $19.38 | 2023 | Valtoco |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhib Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.